Skip to main content

Table 3 Change in clinical characteristics in individuals with progressive glycemic impairment after 2.5 years (n = 23)

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD or n (%)

Baseline

Follow up (2.5 Years)

p-value

Systolic Blood Pressure (mm Hg)

119 ± 20

123 ± 13

0.235

Diastolic Blood Pressure (mm Hg)

71 ± 13

76 ± 13

0.081

Total Cholesterol (mg/dL)

188 ± 39

184 ± 30

0.364

LDL-c (mg/dL)

113 ± 33

106 ± 26

0.091

HDL-c (md/dL)

51 ± 16

51 ± 20

0.895

Triglycerides (mg/dL)

120 ± 65

137 ± 69

0.211

Fasting Blood Glucose (mg/dL)

91 ± 8

101 ± 18

0.008

Insulin (μIU/mL)

11.5 ± 6.2

17.8 ± 6.6

<0.001

HOMA-IR (μIU/mL*mmol/L)

2.6 ± 1.5

4.5 ± 2.1

<0.001

Body Mass Index (kg/m2)

25.7 ± 4.7

26.3 ± 4.9

0.065

Waist Circumference (cm)

93 ± 12

94 ± 13

0.796

  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation